Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN : NSDQ)
 
 • Company Description   
CollPlant Biotechnologies Ltd. is a regenerative medicine company. It is focused on 3D bioprinting of tissues and organs, medical aesthetics and on developing and commercializing tissue repair products for orthobiologics and advanced wound care markets. CollPlant Biotechnologies Ltd., formerly knonw as CollPlant Holdings Ltd., is based in Rehovot, Israel.

Number of Employees: 57

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.40 Daily Weekly Monthly
20 Day Moving Average: 37,873 shares
Shares Outstanding: 12.78 (millions)
Market Capitalization: $17.89 (millions)
Beta: 1.47
52 Week High: $4.98
52 Week Low: $1.30
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -33.33% -33.22%
12 Week -40.17% -41.14%
Year To Date 0.00% 0.00%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
4 OPPENHEIMER ST. 11TH FLOOR
-
REHOVOT,L3 7670104
ISR
ph: 972-73-232-5600
fax: 972-73-232-5602
daniel@lifesciadvisors.com http://www.collplant.com
 
 • General Corporate Information   
Officers
Yehiel Tal - Chief Executive Officer
Eran Rotem - Deputy Chief Executive Officer and Chief Financial
Roger Pomerantz - Chairman of the Board
Oren Fahimipoor - Vice President
Abraham Havron - Director

Peer Information
CollPlant Biotechnologies Ltd. Sponsored ADR (CORR.)
CollPlant Biotechnologies Ltd. Sponsored ADR (RSPI)
CollPlant Biotechnologies Ltd. Sponsored ADR (CGXP)
CollPlant Biotechnologies Ltd. Sponsored ADR (BGEN)
CollPlant Biotechnologies Ltd. Sponsored ADR (GTBP)
CollPlant Biotechnologies Ltd. Sponsored ADR (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: M2R51X116
SIC: 3842
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/25
Next Expected EPS Date: 03/25/26
Share - Related Items
Shares Outstanding: 12.78
Most Recent Split Date: (:1)
Beta: 1.47
Market Capitalization: $17.89 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 03/25/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.91
Price/Cash Flow: -
Price / Sales: 7.23
EPS Growth
vs. Year Ago Period: 28.95%
vs. Previous Quarter: 3.57%
Sales Growth
vs. Year Ago Period: 1,825.00%
vs. Previous Quarter: -56.98%
ROE
12/31/25 - -
09/30/25 - -102.00
06/30/25 - -94.08
ROA
12/31/25 - -
09/30/25 - -72.10
06/30/25 - -68.62
Current Ratio
12/31/25 - -
09/30/25 - 3.66
06/30/25 - 4.60
Quick Ratio
12/31/25 - -
09/30/25 - 3.45
06/30/25 - 4.40
Operating Margin
12/31/25 - -
09/30/25 - -491.19
06/30/25 - -541.34
Net Margin
12/31/25 - -
09/30/25 - -491.31
06/30/25 - -541.34
Pre-Tax Margin
12/31/25 - -
09/30/25 - -491.31
06/30/25 - -541.34
Book Value
12/31/25 - -
09/30/25 - 0.73
06/30/25 - 0.98
Inventory Turnover
12/31/25 - -
09/30/25 - 1.66
06/30/25 - 1.73
Debt-to-Equity
12/31/25 - -
09/30/25 - 0.00
06/30/25 - 0.00
Debt-to-Capital
12/31/25 - -
09/30/25 - 0.00
06/30/25 - 0.00
 

Powered by Zacks Investment Research ©